Influence of Pramipexole Extended Release on Medication Adherence in Real Life Care of Parkinson's Disease.
Phase of Trial: Phase IV
Latest Information Update: 12 Jun 2014
At a glance
- Drugs Pramipexole (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim Pharmaceuticals
- 24 Apr 2012 Actual end date changed from Jul 2011 to Sep 2011 as reported by ClinicalTrials.gov.
- 24 Apr 2012 Actual patient number changed from 330 to 329 as reported by ClinicalTrials.gov.
- 19 Oct 2011 Actual number of patients reported by ClinicalTrials.gov (n=330).